Abingworth as of March 31, 2018
Portfolio Holdings for Abingworth
Abingworth holds 16 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 53.6 | $86M | 1.9M | 45.68 | |
| Sientra | 13.2 | $21M | 2.2M | 9.65 | |
| Paratek Pharmaceuticals | 8.4 | $14M | 1.0M | 13.00 | |
| Gtx Inc Del | 3.7 | $6.0M | 339k | 17.75 | |
| Obseva Sa | 3.6 | $5.8M | 440k | 13.27 | |
| Proteon Therapeutics | 3.1 | $5.0M | 2.0M | 2.50 | |
| Cymabay Therapeutics | 2.2 | $3.6M | 273k | 12.99 | |
| Cellectis S A (CLLS) | 2.0 | $3.2M | 100k | 31.51 | |
| Chiasma | 1.9 | $3.1M | 2.1M | 1.50 | |
| Sierra Oncology | 1.9 | $3.0M | 1.4M | 2.06 | |
| Adaptimmune Therapeutics (ADAP) | 1.7 | $2.8M | 250k | 11.22 | |
| Histogenics Corp Cmn | 1.5 | $2.4M | 889k | 2.75 | |
| Ultragenyx Pharmaceutical (RARE) | 1.2 | $1.9M | 38k | 50.97 | |
| Aurinia Pharmaceuticals (AUPH) | 0.8 | $1.3M | 252k | 5.19 | |
| Immune Design | 0.7 | $1.1M | 352k | 3.25 | |
| Dermira | 0.3 | $559k | 70k | 7.99 |
